The results demonstrated that fisetin treatment significantly promoted proteasomal degradation of MITF in both melanoma and α-MSH-induced melanoma cells by 2.5-fold and 5-fold, respectively (Figure 4C). This evidence concerns the gene STAMBP and melanoma.